IQV Earnings
Tuesday, May 05 2026
EPS Estimate
$2.82
$2.71 – $2.88
Revenue Estimate
$4.1B
Current Price
$176.76
Our Position
bearishAI threatens research division; analysts cut targets 29-6%
structured data
est. revisions stable
(+0.4pp / 30d)
The divergence between Hold and Buy reflects genuine uncertainty about AI's timing and severity. Truist's 65% upside cushion suggests the market may be overreacting, but TD Cowen's sharper cut implies clinical research—IQVIA's largest segment—faces real displacement risk that valuation multiple compression (not just profit revisions) can't yet price in. This is a wait-and-see story, not a fade.
Watch: Watch Q1 2026 guidance and clinical research pricing trends. If CRO clients start shifting work to AI-enabled competitors or renegotiating contract terms downward, the 13-14x EBITDA multiples will fall further. Truist's Buy case depends on that not happening at scale.
Data Signal Summary
1 bullish
2 bearish
Insider selling cluster
Put/call 0.5 (bullish skew)
Price downtrend
Key Context
Insider Activity
selling
Price Trend
downtrend
From 52w High
-0.9%
P/E Ratio
21.9
Est. Revisions (30d)
-0.1% 0up/2dn
Analyst Target (mean)
$232 $185–$287 +31%
Options P/C Ratio
0.54
Est. Dispersion
6% 19 analysts
Insider Cluster
strong sell
Fund Convergence
strong Elliott, Citadel, Appaloosa, D.E. Shaw, Bridgewater
Recent Activity
insider trades
32 transactions
Award
·
BOUSBIB ARI B (Chief Executive Officer)
·57,177 shares
Award
·
BRUEHLMAN RONALD E (Chief Financial Officer)
·16,335 shares
Award
·
SHERBET ERIC M (General Counsel)
·6,806 shares
Award
·
STAUB WALTER. RICHARD III (Officer)
·2,722 shares
Award
·
CHEROFSKY KERIANN (Officer)
·1,087 shares
27 more
Award
·
PATEL BHAVIK
·4,083 shr
Award
·
GRENFELL ALISTAIR
·11,795 shr
Sell
·
BOUSBIB ARI B
·36,564 shr
·$8,132,931
Exercise
·
BOUSBIB ARI B
·50,000 shr
·$2,995,000
Sell
·
BOUSBIB ARI B
·56,557 shr
·$12,461,119
Exercise
·
BOUSBIB ARI B
·77,592 shr
·$4,647,761
Sell
·
SHERBET ERIC M
·4,000 shr
·$878,800
Exercise
·
SHERBET ERIC M
·10,000 shr
·$1,318,200
Sell
·
SHERBET ERIC M
·5,800 shr
·$1,102,290
Exercise
·
SHERBET ERIC M
·11,870 shr
·$1,153,764
Sell
·
CHEROFSKY KERIANN
·549 shr
·$105,150
Award
·
DANHAKL JOHN G
·1,592 shr
Award
·
GOGGINS COLLEEN A
·1,592 shr
Award
·
LEONARD JOHN M
·1,592 shr
Exercise
·
BOUSBIB ARI B
·40,000 shr
·$2,606,400
Award
·
BOUSBIB ARI B
·22,000 shr
Award
·
BRUEHLMAN RONALD E
·6,286 shr
Award
·
SHERBET ERIC M
·2,356 shr
Award
·
STAUB WALTER. RICHARD III
·1,571 shr
Award
·
CHEROFSKY KERIANN
·2,898 shr
Award
·
PATEL BHAVIK
·1,299 shr
Buy
·
DANHAKL JOHN G
·1,275 shr
·$255,740
Sell
·
SHERBET ERIC M
·1,300 shr
·$320,229
Award
·
DANHAKL JOHN G
·1,047 shr
Award
·
CONNAUGHTON JOHN P
·1,047 shr
Award
·
GOGGINS COLLEEN A
·1,047 shr
Award
·
LEONARD JOHN M
·1,047 shr
Explore more
